Should I Buy CTEV? CTEV 2026 Analysis

Should You Buy Claritev Corp (CTEV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

28.150

1 Day change

4.53%

52 Week Range

74.070

Analysis Updated At

2026/01/28

Not a good buy right now for a beginner long-term investor who wants to act immediately. The stock is still in a bearish trend (SMA_200 > SMA_20 > SMA_5) and the latest quarter (2025/Q3) showed sharply worse profitability (net loss and EPS deterioration). While options positioning, hedge-fund flow, and analysts are very bullish, there is no near-term news catalyst and the next major event is earnings on 2026-02-06. I would rate it HOLD today (watch for a trend reversal above the pivot ~29.19 and improving fundamentals before turning bullish).

Technical Analysis

Trend is still down: moving averages are bearishly stacked (SMA_200 > SMA_20 > SMA_5), which typically indicates a sustained downtrend. However, momentum is trying to stabilize: MACD histogram is positive (0.0399) and expanding, suggesting bearish pressure is easing. RSI_6 is ~27.7 (effectively oversold/near-oversold), which often aligns with short-term bounce potential rather than a confirmed long-term reversal. Price is sitting just above key support S1 (26.807) with immediate overhead pivot resistance at 29.189 (then R1 31.571). Near-term pattern-based stats also lean negative (model suggests ~-4.54% over the next month), consistent with the still-bearish MA structure. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options sentiment is strongly call-skewed: put/call ratios are extremely low (OI 0.11; volume 0.03), implying bullish positioning. Call open interest (4,163) dwarfs put OI (459). Activity is modest in raw terms (79 total contracts today), but volume vs 30-day average is elevated (~37.98), suggesting increased attention. Implied volatility is very high (30D IV ~106% vs HV ~129%), but IV rank/percentile are relatively low (rank ~14.5; percentile ~29), meaning volatility is high in absolute terms yet not high versus this stock’s own recent history—consistent with a high-beta name where traders still prefer upside exposure.

Technical Summary

Sell

Buy

Positive Catalysts

and RSI is depressed, which can set up a reflex bounce if buyers defend that level. Next scheduled catalyst: earnings on 2026-02-06 (pre-market).

Neutral/Negative Catalysts

Primary fundamental concern: profitability deteriorated sharply in 2025/Q3 (much larger loss; EPS down ~82% YoY), which can keep long-term investors cautious despite revenue growth. The broader technical trend remains bearish (MA stack bearish), so rallies can fail under resistance (pivot ~29.19). No supportive news flow in the last week, so there is no fresh narrative catalyst to quickly change sentiment. Quant-style pattern expectation also leans slightly negative over the next month (~-4.54%).

Financial Performance

Latest quarter: 2025/Q3. Revenue grew to $245.96M (+6.71% YoY), and gross margin improved to 29.26% (+10.33% YoY), showing top-line resilience and better gross profitability. However, bottom-line performance worsened materially: net income fell to -$69.75M (-82.18% YoY) and EPS dropped to -4.23 (-82.56% YoY). Net losses expanding despite revenue/margin improvement is a negative growth-quality signal for long-term investors until operating costs/other items stabilize.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trend is positive: on 2025-11-10 Piper Sandler raised its price target to $90 from $86 and maintained Overweight; Citi raised its target to $80 from $74 and maintained Buy. Wall Street pros: clear confidence in revenue trajectory (notably analytics/network-based strength) and sustained upgrades. Cons: the market is not rewarding the story yet (price far below targets), and the latest quarter’s sharp EPS/net loss deterioration is the key fundamental contradiction that can keep the stock pressured until it proves a path to improved earnings quality. Politician/congress activity: no recent congress trading data available; no notable influential-figure transactions provided.

3 Analyst Rating

Wall Street analysts forecast CTEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTEV is 62 USD with a low forecast of 33 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 26.930

Low

Averages

High

Current: 26.930

Low

Averages

High

Piper Sandler

Overweight

maintain

$86 -> $90

AI Analysis

2025-11-10

Reason

Piper Sandler

Price Target

$86 -> $90

AI Analysis

2025-11-10

maintain

Overweight

Reason

Piper Sandler raised the firm's price target on Claritev to $90 from $86 and keeps an Overweight rating on the shares. The firm notes Q3 revenue of $246.0M beat consensus at $235.8M and was up 6.7% year-over-year behind continued strength in analytics-based and network-based revenue.

Citi

Buy

upgrade

$74 -> $80

2025-11-10

Reason

Citi

Price Target

$74 -> $80

2025-11-10

upgrade

Buy

Reason

Citi raised the firm's price target on Claritev to $80 from $74 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CTEV

Unlock Now

CTEV Should I Buy

CTEV Should I Buy

Should You Buy Claritev Corp (CTEV) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch